Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age more or equal to 18 and less than 75 years 2.Physician-diagnosed type 2 diabetes treated with not more than or equal to 1 oral hypoglycemic agent concurrent treatment with an injectable non-insulin agent is permitted 3.Hemoglobin A1c HbA1c not more than or equal to 7.0 Percent recorded within the past 30 days. 4. Mobile phone capable of running the protocol-specific applications. 5.Functional English literacy
Exclusion criteria
Exclusion criteria: 1.Unable or unwilling to provide informed consent 2.Unable operate or use the protocol-specified devices and applications or to comply with the study-specified procedures (including food allergies) 3. Unable to fast from midnight the night before the initial study visit 4. Current use of prandial insulin including a continuous insulin infusion pump (basil insulin use alone is permitted) 5. Currently pregnant or planning to become pregnant 6.Estimated life expectancy 7. Active cancer 8. Myocardial infarction or stroke in the last 6 months 9. Receiving or planned to initiate dialysis for end-stage renal disease 10. Receiving oral or intravenous steroids 11. Any contraindication to using a continuous glucose monitor (CGM)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome for the study is postprandial glycemic response (PPGR). Following the Wolever and Jenkins method and logged mealtimes and continuous glucose measurements will be used to calculate the incremental area under the curve (iAUC). Timepoint: Approximately 4 weeks or 29 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Not availableTimepoint: Not available | — |
Countries
India
Contacts
Deciphering Health India Private Limited